Q3 2024 · 13F-HR
Alerce Investment Management, L.P.holdings as filed
Filed 2024-11-13 · accession 0000895345-24-000559
$62.3M
Reported value
5
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03589W102 | ANNX | ANNEXON INC | $43.8M | 70.4% | 7,406,024 | Common | SOLE |
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $7.6M | 12.2% | 5,747,906 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $5.9M | 9.50% | 205,880 | Common | SOLE |
| 03044L204 | AMWL | AMERICAN WELL CORP | $5.0M | 7.97% | 523,785 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $1,358 | 0.00% | 659 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.